---
_id: '66849'
abstract:
- lang: eng
  text: "<jats:title>Abstract</jats:title>\r\n                  <jats:p>\r\n                    Serum
    neurofilament light chain (sNfL) and glial fibrillary acidic protein (GFAP) are
    biomarkers of neuroaxonal and astrocytic damage but remain understudied in adolescent
    psychiatric populations. This study investigated sNfL and GFAP levels in 412 adolescents
    diagnosed with anorexia nervosa (AN) (\r\n                    <jats:italic>n</jats:italic>\r\n
    \                    = 52), depression (\r\n                    <jats:italic>n</jats:italic>\r\n
    \                    = 237), and other psychiatric disorders (\r\n                    <jats:italic>n</jats:italic>\r\n
    \                    = 123). We assessed their diagnostic utility, correlation
    with disease severity, and longitudinal changes during AN treatment. Biomarkers
    were measured using Single Molecule Array technology, with Z-scores derived from
    reference datasets. Compared to population norms, both biomarkers were elevated
    in AN (sNfL: 1.15 ± 1.17; GFAP: 1.50 ± 0.84) and in depression (sNfL: 0.34 ± 1.10;
    GFAP: 0.58 ± 1.00). Patients with AN showed significantly higher biomarker levels
    than those with depression or other psychiatric disorders; importantly, this distinction
    remained evident in sensitivity analyses restricted to underweight individuals
    with depression. In AN, sNfL levels correlated with baseline weight loss (β = −0.45,
    R² = 0.20) and declined significantly during treatment, while GFAP changes were
    less pronounced. Neither marker correlated with depressive symptom severity. Bootstrapped
    ROC analyses showed moderate-to-good discriminatory power (AUCs 0.70–0.84) for
    distinguishing AN from depression. These findings suggest that neuroaxonal and
    astrocytic stress is a component of adolescent psychopathology, particularly in
    AN. sNfL appears sensitive to starvation-related neurobiological changes, with
    levels normalizing alongside weight restoration. GFAP showed similar but less
    robust trends. Accordingly, the observed biomarker changes reflect more than underweight
    alone, supporting a potential role in differential diagnosis and treatment monitoring.\r\n
    \                 </jats:p>"
article_number: '431'
author:
- first_name: Marc
  full_name: Pawlitzki, Marc
  last_name: Pawlitzki
- first_name: Lars
  full_name: Masanneck, Lars
  last_name: Masanneck
- first_name: Laura
  full_name: Schlarbaum, Laura
  id: '96697'
  last_name: Schlarbaum
- first_name: Nicole
  full_name: Jankovic, Nicole
  last_name: Jankovic
- first_name: Stefan
  full_name: Bittner, Stefan
  last_name: Bittner
- first_name: Falk
  full_name: Steffen, Falk
  last_name: Steffen
- first_name: Jens
  full_name: Kuhle, Jens
  last_name: Kuhle
- first_name: Pascal
  full_name: Benkert, Pascal
  last_name: Benkert
- first_name: Jonathan
  full_name: Repple, Jonathan
  last_name: Repple
- first_name: Judith
  full_name: Bühlmeier, Judith
  last_name: Bühlmeier
- first_name: Anke
  full_name: Hinney, Anke
  last_name: Hinney
- first_name: Johannes
  full_name: Hebebrand, Johannes
  last_name: Hebebrand
- first_name: Raphael
  full_name: Hirtz, Raphael
  last_name: Hirtz
- first_name: Sven
  full_name: G. Meuth, Sven
  last_name: G. Meuth
- first_name: Lars
  full_name: Libuda, Lars
  id: '88682'
  last_name: Libuda
  orcid: 0000-0003-1603-3133
- first_name: Manuel
  full_name: Föcker, Manuel
  last_name: Föcker
citation:
  ama: 'Pawlitzki M, Masanneck L, Schlarbaum L, et al. Exploring serum biomarkers
    in paediatric psychiatry: the impact of NfL and GFAP. <i>Translational Psychiatry</i>.
    2026;16(1). doi:<a href="https://doi.org/10.1038/s41398-026-04347-1">10.1038/s41398-026-04347-1</a>'
  apa: 'Pawlitzki, M., Masanneck, L., Schlarbaum, L., Jankovic, N., Bittner, S., Steffen,
    F., Kuhle, J., Benkert, P., Repple, J., Bühlmeier, J., Hinney, A., Hebebrand,
    J., Hirtz, R., G. Meuth, S., Libuda, L., &#38; Föcker, M. (2026). Exploring serum
    biomarkers in paediatric psychiatry: the impact of NfL and GFAP. <i>Translational
    Psychiatry</i>, <i>16</i>(1), Article 431. <a href="https://doi.org/10.1038/s41398-026-04347-1">https://doi.org/10.1038/s41398-026-04347-1</a>'
  bibtex: '@article{Pawlitzki_Masanneck_Schlarbaum_Jankovic_Bittner_Steffen_Kuhle_Benkert_Repple_Bühlmeier_et
    al._2026, title={Exploring serum biomarkers in paediatric psychiatry: the impact
    of NfL and GFAP}, volume={16}, DOI={<a href="https://doi.org/10.1038/s41398-026-04347-1">10.1038/s41398-026-04347-1</a>},
    number={1431}, journal={Translational Psychiatry}, publisher={Springer Science
    and Business Media LLC}, author={Pawlitzki, Marc and Masanneck, Lars and Schlarbaum,
    Laura and Jankovic, Nicole and Bittner, Stefan and Steffen, Falk and Kuhle, Jens
    and Benkert, Pascal and Repple, Jonathan and Bühlmeier, Judith and et al.}, year={2026}
    }'
  chicago: 'Pawlitzki, Marc, Lars Masanneck, Laura Schlarbaum, Nicole Jankovic, Stefan
    Bittner, Falk Steffen, Jens Kuhle, et al. “Exploring Serum Biomarkers in Paediatric
    Psychiatry: The Impact of NfL and GFAP.” <i>Translational Psychiatry</i> 16, no.
    1 (2026). <a href="https://doi.org/10.1038/s41398-026-04347-1">https://doi.org/10.1038/s41398-026-04347-1</a>.'
  ieee: 'M. Pawlitzki <i>et al.</i>, “Exploring serum biomarkers in paediatric psychiatry:
    the impact of NfL and GFAP,” <i>Translational Psychiatry</i>, vol. 16, no. 1,
    Art. no. 431, 2026, doi: <a href="https://doi.org/10.1038/s41398-026-04347-1">10.1038/s41398-026-04347-1</a>.'
  mla: 'Pawlitzki, Marc, et al. “Exploring Serum Biomarkers in Paediatric Psychiatry:
    The Impact of NfL and GFAP.” <i>Translational Psychiatry</i>, vol. 16, no. 1,
    431, Springer Science and Business Media LLC, 2026, doi:<a href="https://doi.org/10.1038/s41398-026-04347-1">10.1038/s41398-026-04347-1</a>.'
  short: M. Pawlitzki, L. Masanneck, L. Schlarbaum, N. Jankovic, S. Bittner, F. Steffen,
    J. Kuhle, P. Benkert, J. Repple, J. Bühlmeier, A. Hinney, J. Hebebrand, R. Hirtz,
    S. G. Meuth, L. Libuda, M. Föcker, Translational Psychiatry 16 (2026).
date_created: 2026-08-26T08:23:11Z
date_updated: 2026-08-26T08:26:16Z
ddc:
- '570'
doi: 10.1038/s41398-026-04347-1
file:
- access_level: closed
  content_type: application/pdf
  creator: laura36
  date_created: 2026-08-26T08:23:55Z
  date_updated: 2026-08-26T08:23:55Z
  file_id: '66850'
  file_name: s41398-026-04347-1.pdf
  file_size: 2476361
  relation: main_file
  success: 1
file_date_updated: 2026-08-26T08:23:55Z
has_accepted_license: '1'
intvolume: '        16'
issue: '1'
language:
- iso: eng
publication: Translational Psychiatry
publication_identifier:
  issn:
  - 2158-3188
publication_status: published
publisher: Springer Science and Business Media LLC
status: public
title: 'Exploring serum biomarkers in paediatric psychiatry: the impact of NfL and
  GFAP'
type: journal_article
user_id: '96697'
volume: 16
year: '2026'
...
